Molecular Cryoprotection Technologies
1. 718. 845. 7374

News in Science

Evergreen
  /   News

LabCorp's CRO unit Covance doubles down on cell, gene therapy offerings

LabCorp has unveiled a new suite of cell and gene therapy development offerings from Covance as it looks to get in on this burgeoning new trend.

Published: 

January 21, 2020

cell and gene therapy

IP or Not IP: That Is the Question for Cell and Gene Therapy Sector

Cell and gene therapy manufacturing may never be standardized but the whole industry would gain if firms collaborated to develop common methods for some processes according to an expert.

Published: 

December 24, 2019

Cell Therapy

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina

NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment.

Published: 

December 16, 2019

cell therapy

McLean's Brain Bank receives new contract from NIH

The McLean Hospital Brain Bank is proud to be 1 of 6 brain banks that are part of the NIH NeuroBioBank

Published: 

October 28, 2019

science

Q3 2019 Data Report of Alliance of Regenerative Medicine

This quarterly data report details industry-specific statistics compiled from hundreds of cell therapy, gene therapy, tissue engineering, and other regenerative medicine therapeutic developers worldwide, including total financings, partnerships and other deals, clinical trial information, key clinical data events, and ARM’s current strategic priorities.

Published: 

Regenerative Medicine

Molecular Cryoprotection Technologies
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Follow us on social media
Services
Primary Neurons E-commerceOrgan & Tissue Cryopreservation & BankingCell & Gene TherapyCell Production & Cryoprotection Consulting
Company
NewsContactCareers
Evergreeen Biosciences, Inc.
49 West 38th Street, 11th FL
New York, NY 10018

Tel. 718.845.7374
Fax. 212.302.6141
email: